157 related articles for article (PubMed ID: 28887716)
1. Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells.
Pan M; Hou L; Zhang J; Zhao D; Hua J; Wang Z; He J; Jiang H; Hu H; Zhang L
Mol Cell Biochem; 2018 Apr; 441(1-2):63-76. PubMed ID: 28887716
[TBL] [Abstract][Full Text] [Related]
2. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
[TBL] [Abstract][Full Text] [Related]
3. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cells.
Sahin E; Baycu C; Koparal AT; Burukoglu Donmez D; Bektur E
Tumour Biol; 2016 Jun; 37(6):7573-82. PubMed ID: 26687643
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
7. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway.
Choe C; Shin YS; Kim SH; Jeon MJ; Choi SJ; Lee J; Kim J
Anticancer Res; 2013 Sep; 33(9):3715-23. PubMed ID: 24023301
[TBL] [Abstract][Full Text] [Related]
8. The effect of mesenchymal stem cells' secretome on lung cancer progression is contingent on their origin: primary or metastatic niche.
Attar-Schneider O; Drucker L; Gottfried M
Lab Invest; 2018 Dec; 98(12):1549-1561. PubMed ID: 30089856
[TBL] [Abstract][Full Text] [Related]
9. Claudin-7 suppresses the cytotoxicity of TRAIL-expressing mesenchymal stem cells in H460 human non-small cell lung cancer cells.
Xia P; Wang W; Bai Y
Apoptosis; 2014 Mar; 19(3):491-505. PubMed ID: 24242915
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
[TBL] [Abstract][Full Text] [Related]
11. [Investigational Study of Mesenchymal Stem Cells on Lung Cancer Cell Proliferation and Invasion].
Li M; Wu Y; Liu R; Guo L; Xu T; Chen J; Xu S
Zhongguo Fei Ai Za Zhi; 2015 Nov; 18(11):674-9. PubMed ID: 26582222
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of fascin-1 expression suppresses cell migration and invasion of non-small cell lung cancer by regulating the MAPK pathway.
Zhao D; Zhang T; Hou XM; Ling XL
Biochem Biophys Res Commun; 2018 Mar; 497(2):694-699. PubMed ID: 29458026
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
Lin M; Bi H; Yan Y; Huang W; Zhang G; Zhang G; Tang S; Liu Y; Zhang L; Ma J; Zhang J
Oncotarget; 2017 Apr; 8(14):23436-23447. PubMed ID: 28423582
[TBL] [Abstract][Full Text] [Related]
14. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
15. Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway.
Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
Biomed Pharmacother; 2017 Jun; 90():437-445. PubMed ID: 28391165
[TBL] [Abstract][Full Text] [Related]
16. The Inhibitory Effect of Mesenchymal Stem Cells with rAd-NK4 on Liver Cancer.
Cai C; Hou L; Zhang J; Zhao D; Wang Z; Hu H; He J; Guan W; Ma Y
Appl Biochem Biotechnol; 2017 Sep; 183(1):444-459. PubMed ID: 28353041
[TBL] [Abstract][Full Text] [Related]
17. SCUBE2 inhibits the proliferation, migration and invasion of human non-small cell lung cancer cells through regulation of the sonic hedgehog signaling pathway.
Yang B; Miao S; Li Y
Gene; 2018 Sep; 672():143-149. PubMed ID: 29883759
[TBL] [Abstract][Full Text] [Related]
18. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
19. The Nutritional Cytokine Leptin Promotes NSCLC by Activating the PI3K/AKT and MAPK/ERK Pathways in NSCLC Cells in a Paracrine Manner.
Li F; Zhao S; Guo T; Li J; Gu C
Biomed Res Int; 2019; 2019():2585743. PubMed ID: 31119158
[TBL] [Abstract][Full Text] [Related]
20. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
